-
公开(公告)号:US20240269074A1
公开(公告)日:2024-08-15
申请号:US18617058
申请日:2024-03-26
Applicant: SUZHOU ABOGEN BIOSCIENCES CO., LTD.
Inventor: Bo YING , Xiulian WANG
IPC: A61K9/16 , C07C217/28 , C07C219/06 , C07C229/16 , C07C229/22 , C07C235/06 , C07D207/24 , C07D295/13
CPC classification number: A61K9/1617 , C07C217/28 , C07C219/06 , C07C229/16 , C07C229/22 , C07C235/06 , C07D207/24 , C07D295/13 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2601/18
Abstract: Provided herein are lipid compounds that can be used in combination with other lipid components, such as neutral lipids, cholesterol and polymer conjugated lipids, to form lipid nanoparticles for delivery of therapeutic agents (e.g., nucleic acid molecules) for therapeutic or prophylactic purposes, including vaccination. Also provided herein are lipid nanoparticle compositions comprising said lipid compounds.
-
公开(公告)号:US20240238212A1
公开(公告)日:2024-07-18
申请号:US18558353
申请日:2023-01-18
Applicant: SUZHOU ABOGEN BIOSCIENCES CO., LTD.
Inventor: XiuLian WANG , Bo YING
IPC: A61K9/51 , A61K39/00 , C07C217/28 , C07C217/40 , C07C219/06
CPC classification number: A61K9/5123 , A61K39/0011 , C07C217/28 , C07C217/40 , C07C219/06
Abstract: Provided herein are lipid compounds that can be used in combination with other lipid components, such as neutral lipids, cholesterol and polymer conjugated lipids, to form lipid nanoparticles for delivery of therapeutic agents (e.g., nucleic acid molecules) for therapeutic or prophylactic purposes, including vaccination. Also provided herein are lipid nanoparticle compositions comprising said lipid compounds.
-
公开(公告)号:US11542450B2
公开(公告)日:2023-01-03
申请号:US16661822
申请日:2019-10-23
Applicant: Thomas Daly
Inventor: Thomas Daly
IPC: C10L1/2387 , C10L1/233 , C10L1/26 , C10L1/24 , C10L1/222 , C07C205/15 , C07C205/40 , C07C215/08 , C07C217/08 , C07C217/28 , C07C217/48 , C07C219/06 , C07C219/22 , C07C229/12 , C07C229/22 , C07C309/14 , C07D213/74 , C07D295/088 , C07D295/15 , C07F9/09 , C07F9/38 , C07F9/58 , C09K3/00 , C10L1/10 , C10L1/22 , C10L1/238 , C11D1/66
Abstract: Amines and amine derivatives that improve the buffering range, and/or reduce the chelation and other negative interactions of the buffer and the system to be buffered. The reaction of amines or polyamines with various molecules to form polyamines with differing pKa's will extend the buffering range, derivatives that result in polyamines that have the same pKa yields a greater buffering capacity. Derivatives that result in zwitterionic buffers improve yield by allowing a greater range of stability.
-
公开(公告)号:US11471533B2
公开(公告)日:2022-10-18
申请号:US16336668
申请日:2017-09-27
Applicant: Kyowa Kirin Co., Ltd.
Inventor: Shintaro Hosoe , Hayato Yabuuchi
IPC: A61K47/18 , A61K9/00 , C07C217/28 , C12N15/113
Abstract: The present invention provides a compound represented by formula (I) usable as a cationic lipid that facilitates introduction of a nucleic acid, for example, into a cell, and a composition or the like containing the compound.
-
公开(公告)号:US11434195B2
公开(公告)日:2022-09-06
申请号:US16632721
申请日:2018-07-20
Inventor: Stanislav Igorevich Svetlov
IPC: C07C217/28 , A61K31/133
Abstract: Compounds, pharmaceutical compositions, and methods for treating cancer, in particular brain cancer, are provided, including amphiphilic fatty acid/alcohol ethers (AIPs) comprising endocannabinoid and FABP motifs covalently linked to a beta-adrenoreceptor antagonist motif in one molecule. The invention includes methods for inhibiting growth of brain cancer cells by contacting the compound(s) with brain cancer cells. The invention provides a method for treating both brain cancer and brain cancer metastases, and for suppression of regrowth of brain cancer cells after radiation, surgical treatment, or chemotherapy of brain cancer. The invention also comprises an optimized chemical synthesis of the AIP compounds and methods of using the compounds, alone or in combination with another agent, for suppressing the growth of brain cancer cells, and enhancing survival of normal CNS cells, or improving recuperation from radiation, surgical or chemotherapy.
-
公开(公告)号:US20210275672A1
公开(公告)日:2021-09-09
申请号:US16336668
申请日:2017-09-27
Applicant: Kyowa Kirin Co., Ltd.
Inventor: Shintaro HOSOE , Hayato YABUUCHI
IPC: A61K47/18 , C07C217/28 , C12N15/113 , A61K9/00
Abstract: The present invention provides a compound represented by formula (I) usable as a cationic lipid that facilitates introduction of a nucleic acid, for example, into a cell, and a composition or the like containing the compound.
-
公开(公告)号:US11098006B2
公开(公告)日:2021-08-24
申请号:US16082785
申请日:2017-03-10
Applicant: RYBOQUIN COMPANY LTD
Inventor: Helen Claire Hailes , Alethea Bernice Tabor , Mohn Firouz Mohd Mustapa , Stephen Lewis Hart , Aristides Tagalakis
IPC: C07C217/28 , A61K47/54 , A61P35/00
Abstract: A lipid comprising a tri-chain cation having a cationic head group and three or more C7-24 hydrocarbyl groups for use in non-viral gene delivery systems, for example in the formation of lipopolyplex transfection vectors. Exceptionally good nucleic acid transfection is observed when nucleic acid and targeting peptides are formulated with the lipid of the invention (or lipid formulated with a co-lipid) into a LPD complex.
-
公开(公告)号:US20190084923A1
公开(公告)日:2019-03-21
申请号:US16082785
申请日:2017-03-10
Applicant: RYBOQUIN COMPANY LTD
Inventor: Helen Claire HAILES , Alethea Bernice TABOR , Mohn Firouz MOHD MUSTAPA , Stephen Lewis HART , Aristides TAGALAKIS
IPC: C07C217/28 , A61P35/00 , A61K47/54
Abstract: A lipid comprising a tri-chain cation having a cationic head group and three or more C7-24 hydrocarbyl groups for use in non-viral gene delivery systems, for example in the formation of lipopolyplex transfection vectors. Exceptionally good nucleic acid transfection is observed when nucleic acid and targeting peptides are formulated with the lipid of the invention (or lipid formulated with a co-lipid) into a LPD complex.
-
公开(公告)号:US10207217B2
公开(公告)日:2019-02-19
申请号:US15506635
申请日:2015-08-20
Applicant: BASF SE
Inventor: Thomas Ingram , Ralf Notz , Gerald Vorberg , Georg Sieder
IPC: B01D53/14 , B01D53/52 , B01D53/78 , B01D53/96 , C07C217/08 , C07C217/28 , C07C217/42
Abstract: A process for removing hydrogen sulfide and carbon dioxide from a fluid stream comprises a) an absorption step in which the fluid stream is contacted with an absorbent comprising an aqueous solution (i) of an amine of the general formula (I) in which R1, R2 and R3 are each independently selected from C1-4-alkyl and C1-4-hydroxyalkyl; each R4 is independently selected from hydrogen, C1-4-alkyl and C1-4-hydroxyalkyl; each R5 is independently selected from hydrogen, C1-4-alkyl and C1-4-hydroxyalkyl; X is OH or NH(CR1R2R3); m is 2, 3, 4 or 5; n is 2, 3, 4 or 5; and o is 0 or 1; and optionally (ii) at least one tertiary amine, where the molar ratio of (i) to (ii) is greater than 0.05; wherein at least 90% of the hydrogen sulfide is removed from the fluid stream and selectivity for hydrogen sulfide over carbon dioxide is not greater than 8, wherein a CO2- and H2S-laden absorbent is obtained; b) a regeneration step in which at least a substream of the CO2- and H2S-laden absorbent is regenerated and a regenerated absorbent is obtained; and c) a recycling step in which at least a substream of the regenerated absorbent is recycled into the absorption step a). The process allows a high level of hydrogen sulfide removal with a simultaneously high coabsorption of carbon dioxide.
-
公开(公告)号:US20180044280A1
公开(公告)日:2018-02-15
申请号:US15791405
申请日:2017-10-23
Applicant: JENKEM TECHNOLOGY CO., LTD. (BEIJING)
Inventor: Hui ZHU , Meina LIN , Xiaomeng CHEN , Zhen'gang ZHU , Xuan ZHAO
IPC: C07C217/28 , C08G65/26 , C07C213/06
CPC classification number: C07C217/28 , C07C213/02 , C07C213/06 , C07C217/08 , C08G65/2618 , C08G65/33306 , C08G65/33396 , C08G65/3344 , C08G2650/30 , C08G2650/50
Abstract: The present invention discloses a Y-type discrete polyethylene glycol derivative and a preparation method thereof, which has the advantages of determined molecular weights and the number of chain segments, and can avoid the defect of heterogeneity of a PEG derivative, meanwhile the preparation method has simple steps, mild conditions, without need for strictly anhydrous environment or performing protection and deprotection steps. In addition, the Y-type discrete polyethylene glycol derivative of the present invention may increase the water solubility of the discrete polyethylene glycol, and solve the problem of insufficient water solubility of the discrete polyethylene glycol-modified insoluble drug caused by an increase of the loading capacity.
-
-
-
-
-
-
-
-
-